AXL and cancer: In an unbiased analysis of 643 human cancer cell lines, AXL was strongly associated with a drug-resistant mesenchymal phenotype, and inhibition of AXL displayed a specifically synergistic effect together with antimitotic drugs such as docetaxel (121).